Publications
Showing records 1 - 20 (of 51)
Publication: JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID
Author
Year
Title
Publisher
4656851 Meier, Daniel T; Rachid, Leila; Wiedemann, Sophia J; Traub, Shuyang; Trimigliozzi, Kelly; Stawiski, Marc; Sauteur, Loïc; Winter, Denise V; Le Foll, Christelle; Brégère, Catherine; Guzman, Raphael; Odermatt, Alex; Böni-Schnetzler, Marianne; Donath, Marc Y
2022
Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing.
Nature communications
4501676 Trinh, Beckey; Hepprich, Matthias; Betz, Matthias J.; Burkard, Thilo; Cavelti-Weder, Claudia; Seelig, Eleonora; Meienberg, Fabian; Kratschmar, Denise V.; Beuschlein, Felix; Reincke, Martin; Odermatt, Alex; Hall, Michael N.; Donath, Marc Y.; Swierczynska, Marta M.
2019
Treatment of Primary Aldosteronism with mTORC1 Inhibitors
The Journal of Clinical Endocrinology and Metabolism
4378964 Seelig, Eleonora; Timper, Katharina; Falconnier, Claudine; Stoeckli, Rolf; Bilz, Stefan; Oram, Richard A.; McDonald, Timothy James; Donath, Marc Y.
2016
Interleukin-1 antagonism in type 1 diabetes of long duration
Diabetes & metabolism
4378963 Timper, K.; Dalmas, E.; Dror, E.; Rutti, S.; Thienel, C.; Sauter, N. S.; Bouzakri, K.; Bedat, B.; Pattou, F.; Kerr-Conte, J.; Boni-Schnetzler, M.; Donath, M. Y.
2016
Glucose-Dependent Insulinotropic Peptide Stimulates Glucagon-Like Peptide 1 Production by Pancreatic Islets via Interleukin 6, Produced by α Cells
Gastroenterology
4376830 Cavelti-Weder, C.; Timper, K.; Seelig, E.; Keller, C.; Osranek, M.; Lassing, U.; Spohn, G.; Maurer, P.; Muller, P.; Jennings, G. T.; Willers, J.; Saudan, P.; Donath, M. Y.; Bachmann, M. F.
2016
Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes
Molecular Therapy
4378965 Pollack, Rena M.; Donath, Marc Y.; LeRoith, Derek; Leibowitz, Gil
2016
Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications
Diabetes Care
4378969 Timper, K.; Seelig, E.; Tsakiris, D. A.; Donath, M. Y.
2015
Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus
Journal of Diabetes and its Complications
4378974 Caduff, Andreas; Zanon, Mattia; Mueller, Martin; Zakharov, Pavel; Feldman, Yuri; De Feo, Oscar; Donath, Marc; Stahel, Werner A.; Talary, Mark S.
2015
The Effect of a Global, Subject, and Device-Specific Model on a Noninvasive Glucose Monitoring Multisensor System
Journal of Diabetes Science and Technology
4378971 Nordmann, Thierry M.; Seelig, Eleonara; Timper, Katharina; Cordes, Mareike; Coslovsky, Michael; Hanssen, Henner; Schmidt-Trucksäss, Arno; Donath, Marc Y.
2015
Muscle-Derived IL-6 Is Not Regulated by IL-1 during Exercise. A Double Blind, Placebo-Controlled, Randomized Crossover Study
PLoS ONE
4378970 Sauter, N. S.; Thienel, C.; Plutino, Y.; Kampe, K.; Dror, E.; Traub, S.; Timper, K.; Bedat, B.; Pattou, F.; Kerr-Conte, J.; Jehle, A. W.; Boni-Schnetzler, M.; Donath, M. Y.
2015
Angiotensin II Induces Interleukin-1β–Mediated Islet Inflammation and β-Cell Dysfunction Independently of Vasoconstrictive Effects
Diabetes
4378975 Wueest, Stephan; Item, Flurin; Boyle, Christina N.; Jirkof, Paulin; Cesarovic, NNikola; Ellingsgaard, Helga; Böni-Schnetzler, Marianne; Timper, Katharina; Arras, Margarete; Donath, Marc Y.; Lutz, Thomas A.; Schoenle, Eugen J.; Konrad, Daniel
2014
Interleukin-6 contributes to early fasting-induced free fatty acid mobilization in mice
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
4378977 Donath, Marc Y.; Hess, Christoph; Palmer, Ed
2014
What is the role of autoimmunity in type 1 diabetes? A clinical perspective
Diabetologia
4378976 Rutti, Sabine; Arous, Caroline; Schvartz, Domitille; Timper, Katharina; Sanchez, Jean-Charles; Dermitzakis, Emmanouil; Donath, Marc Y.; Halban, Philippe A.; Bouzakri, Karim
2014
Fractalkine (CX3CL1), a new factor protecting beta-cells against TNFalpha
Molecular Metabolism
2833317 Donath, Marc Y; Burcelin, Rémy
2013
GLP-1 effects on islets: hormonal, neuronal, or paracrine?
Diabetes care
2833327 Timper, Katharina; Hruz, Petr; Beglinger, Christoph; Donath, Marc Y
2013
Infliximab in the treatment of Crohn disease and type 1 diabetes
Diabetes care
2833323 Moran, Antoinette; Bundy, Brian; Becker, Dorothy J.; DiMeglio, Linda A.; Gitelman, Stephen E.; Goland, Robin; Greenbaum, Carla J.; Herold, Kevan C.; Marks, Jennifer B.; Raskin, Philip; Sanda, Srinath; Schatz, Desmond; Wherrett, Diane K.; Wilson, Darrell M.; Krischer, Jeffrey P.; Skyler, Jay S.; Pickersgill, Linda; de Koning, Eelco; Ziegler, Anette-G; Boeehm, Bernhard; Badenhoop, Klaus; Schloot, Nanette; Bak, Jens Friis; Pozzilli, Paolo; Mauricio, Didac; Donath, Marc Y.; Castano, Luis; Waegner, Ana; Lervang, Hans Henrik; Perrild, Hans; Mandrup-Poulsen, Thomas; Type 1 Diabet TrialNet Canakinumab; AIDA Study Grp
2013
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Lancet
2833315 Donath, M Y
2013
Targeting inflammation in the treatment of type 2 diabetes
Diabetes, obesity and metabolism
2833318 Donath, Marc Y; Dalmas, Élise; Sauter, Nadine S; Böni-Schnetzler, Marianne
2013
Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity
Cell metabolism
2833325 Tang, Christine; Naassan, Anthony E; Chamson-Reig, Astrid; Koulajian, Khajag; Goh, Tracy T; Yoon, Frederick; Oprescu, Andrei I; Ghanim, Husam; Lewis, Gary F; Dandona, Paresh; Donath, Marc Y; Ehses, Jan A; Arany, Edith; Giacca, Adria
2013
Susceptibility to fatty acid-induced beta-cell dysfunction is enhanced in prediabetic diabetes-prone biobreeding rats: a potential link between beta-cell lipotoxicity and islet inflammation
Endocrinology
2833324 Rutti, S.; Sauter, N. S.; Bouzakri, K.; Prazak, R.; Halban, P. A.; Donath, M. Y.
2012
In vitro proliferation of adult human beta-cells
PLoS ONE
Showing records 1 - 20 (of 51)
